An Open Label Phase 2 Study of MLN0128 in Combination wi

Project: Research project

Project Details

Description

An Open Label Phase 2 Study of MLN0128 in Combination with Fulvestrant in Women with ERPositive/ HER2 Negative Advanced or Metastatic Breast Cancer that has Progressed During or AFter Aromatase Inhibitor Therapy
StatusActive
Effective start/end date1/1/171/30/23

Funding

  • MILLENNIUM PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.